BIOLASE (NASDAQ:BIOL) Research Coverage Started at StockNews.com

Equities researchers at StockNews.com began coverage on shares of BIOLASE (NASDAQ:BIOL) in a research note issued to investors on Thursday. The firm set a “sell” rating on the medical technology company’s stock.

Several other equities research analysts have also issued reports on BIOL. Benchmark restated a “speculative buy” rating and issued a $0.40 target price on shares of BIOLASE in a report on Wednesday. Ascendiant Capital Markets reduced their price objective on shares of BIOLASE from $3.50 to $2.00 and set a “buy” rating on the stock in a research report on Tuesday, September 3rd.

BIOLASE Price Performance

Shares of BIOL stock opened at $0.02 on Thursday. The company has a market cap of $579,611.45, a PE ratio of 0.00 and a beta of 0.66. BIOLASE has a 1 year low of $0.02 and a 1 year high of $1.94. The stock’s 50 day simple moving average is $0.06 and its two-hundred day simple moving average is $0.11.

BIOLASE (NASDAQ:BIOL) last released its quarterly earnings results on Thursday, August 8th. The medical technology company reported ($0.08) earnings per share for the quarter. The company had revenue of $11.56 million for the quarter. BIOLASE had a negative net margin of 41.65% and a negative return on equity of 1,782.73%.

Institutional Trading of BIOLASE

A hedge fund recently raised its stake in BIOLASE stock. Virtu Financial LLC grew its stake in shares of BIOLASE, Inc. (NASDAQ:BIOL) by 1,068.0% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 143,537 shares of the medical technology company’s stock after acquiring an additional 131,248 shares during the period. Virtu Financial LLC owned about 0.43% of BIOLASE worth $27,000 at the end of the most recent quarter. 8.79% of the stock is owned by institutional investors.

About BIOLASE

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.